UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 143

Sortiert nach

Gene Therapy in HIV-Infected Cells to Decrease Viral Impact by Using an Alternative Delivery Method

ChemMedChem, 2010-06, Vol.5 (6), p.921-929

2010

Volltextzugriff (PDF)

Changes in the Expression of TGF-Beta Regulatory Pathway Genes Induced by Vitamin D in Patients with Relapsing-Remitting Multiple Sclerosis

International journal of molecular sciences, 2023-10, Vol.24 (19), p.14447

2023

Volltextzugriff (PDF)

Pharmacogenetics to Avoid Adverse Drug Reactions

Journal of personalized medicine, 2022-01, Vol.12 (2), p.159

López-Fernández, Luis A

2022

Volltextzugriff (PDF)

Regulatory CDH4 Genetic Variants Associate With Risk to Develop Capecitabine‐Induced Hand‐Foot Syndrome

Clinical pharmacology and therapeutics, 2021-02, Vol.109 (2), p.462-470

2021

Volltextzugriff (PDF)

Differential Expression of SMAD Genes and S1PR1 on Circulating CD4+ T Cells in Multiple Sclerosis and Crohn's Disease

International journal of molecular sciences, 2020-01, Vol.21 (2), p.676

2020

Volltextzugriff (PDF)

Biomarkers for Optimization and Personalization of Anti-TNFs in Pediatric Inflammatory Bowel Disease

Pharmaceutics, 2021-10, Vol.13 (11), p.1786

2021

Volltextzugriff (PDF)

Clinical Relevance of Novel Polymorphisms in the Dihydropyrimidine Dehydrogenase ( DPYD ) Gene in Patients with Severe Fluoropyrimidine Toxicity: A Spanish Case-Control Study

Pharmaceutics, 2021-11, Vol.13 (12), p.2036

2021

Volltextzugriff (PDF)

Distinct Gene Expression Profiling after Infection of Immature Human Monocyte-Derived Dendritic Cells by the Attenuated Poxvirus Vectors MVA and NYVAC

Journal of Virology, 2007-08, Vol.81 (16), p.8707-8721

2007

Volltextzugriff (PDF)

Pharmacogenetic markers of toxicity for chemotherapy in colorectal cancer patients

Pharmacogenomics, 2012-07, Vol.13 (10), p.1173-1191

2012

Volltextzugriff (PDF)

Differential toxicity biomarkers for irinotecan- and oxaliplatin-containing chemotherapy in colorectal cancer

Cancer chemotherapy and pharmacology, 2013-06, Vol.71 (6), p.1463-1472

2013

Volltextzugriff (PDF)

ATP-Binding Cassette Transporters in the Clinical Implementation of Pharmacogenetics

Journal of personalized medicine, 2018-12, Vol.8 (4), p.40

López-Fernández, Luis A

2018

Volltextzugriff (PDF)

Microarray Analysis Reveals Characteristic Changes of Host Cell Gene Expression in Response to Attenuated Modified Vaccinia Virus Ankara Infection of Human HeLa Cells

Journal of Virology, 2004-06, Vol.78 (11), p.5820-5834

2004

Volltextzugriff (PDF)

Selective Induction of Host Genes by MVA-B, a Candidate Vaccine against HIV/AIDS

Journal of Virology, 2010-08, Vol.84 (16), p.8141-8152

2010

Volltextzugriff (PDF)

Comparison of a new rapid method for determination of serum anti-adalimumab and anti-infliximab antibodies with two established ELISA kits

Journal of pharmaceutical and biomedical analysis, 2021-05, Vol.198, p.114003-114003, Article 114003

2021

Volltextzugriff (PDF)

The effects of different endocrine disruptors defining compound-specific alterations of gene expression profiles in the developing testis

Reproductive toxicology (Elmsford, N.Y.), 2012-01, Vol.33 (1), p.106-115

2012

Volltextzugriff (PDF)

Carbosilane Dendrimers to Transfect Human Astrocytes with Small Interfering RNA Targeting Human Immunodeficiency Virus

BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, 2010-10, Vol.24 (5), p.331-343

2010

Volltextzugriff (PDF)

Evaluating the role of ENOSF1 and TYMS variants as predictors in fluoropyrimidine-related toxicities: An IPD meta-analysis

Pharmacological research, 2020-02, Vol.152, p.104594, Article 104594

2020

Volltextzugriff (PDF)

Comparison of a new rapid method for the determination of adalimumab serum levels with two established ELISA kits

Clinical chemistry and laboratory medicine, 2019-11, Vol.57 (12), p.1906

2019

Volltextzugriff (PDF)

Genetic predictors of long-term response and trough levels of infliximab in crohn’s disease

Pharmacological research, 2019-11, Vol.149, p.104478-104478, Article 104478

2019

Volltextzugriff (PDF)

Identification of new SNPs associated with severe toxicity to capecitabine

Pharmacological research, 2017-06, Vol.120, p.133-137

2017

Volltextzugriff (PDF)

Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children

Pharmacological research, 2023-08, Vol.194, p.106859-106859, Article 106859

2023

Volltextzugriff (PDF)

Cost-effectiveness of screening for DPYD polymorphisms to prevent neutropenia in cancer patients treated with fluoropyrimidines

Pharmacogenomics, 2016-06, Vol.17 (9), p.979-984

2016

Volltextzugriff (PDF)

The Effect of Polymorphisms and Other Biomarkers on Infliximab Exposure in Paediatric Inflammatory Bowel Disease: Development of a Population Pharmacokinetic Model

Paediatric drugs, 2024-05, Vol.26 (3), p.331-346

2024

Volltextzugriff (PDF)

1 – 25 von 143

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(121)
Mit Volltextzugriff
(120)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(2)
... seit 30 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Gene Therapy in HIV-Infected Cells to Decrease Viral Impact by Using an Alternative Delivery Method

Changes in the Expression of TGF-Beta Regulatory Pathway Genes Induced by Vitamin D in Patients with Relapsing-Remitting Multiple Sclerosis

Pharmacogenetics to Avoid Adverse Drug Reactions

Regulatory CDH4 Genetic Variants Associate With Risk to Develop Capecitabine‐Induced Hand‐Foot Syndrome

Differential Expression of SMAD Genes and S1PR1 on Circulating CD4+ T Cells in Multiple Sclerosis and Crohn's Disease

Biomarkers for Optimization and Personalization of Anti-TNFs in Pediatric Inflammatory Bowel Disease

Clinical Relevance of Novel Polymorphisms in the Dihydropyrimidine Dehydrogenase ( DPYD ) Gene in Patients with Severe Fluoropyrimidine Toxicity: A Spanish Case-Control Study

Distinct Gene Expression Profiling after Infection of Immature Human Monocyte-Derived Dendritic Cells by the Attenuated Poxvirus Vectors MVA and NYVAC

Pharmacogenetic markers of toxicity for chemotherapy in colorectal cancer patients

Differential toxicity biomarkers for irinotecan- and oxaliplatin-containing chemotherapy in colorectal cancer

ATP-Binding Cassette Transporters in the Clinical Implementation of Pharmacogenetics

Microarray Analysis Reveals Characteristic Changes of Host Cell Gene Expression in Response to Attenuated Modified Vaccinia Virus Ankara Infection of Human HeLa Cells

A colorectal cancer genome-wide association study in a Spanish cohort identifies two variants associated with colorectal cancer risk at 1p33 and 8p12

Selective Induction of Host Genes by MVA-B, a Candidate Vaccine against HIV/AIDS

Comparison of a new rapid method for determination of serum anti-adalimumab and anti-infliximab antibodies with two established ELISA kits

The effects of different endocrine disruptors defining compound-specific alterations of gene expression profiles in the developing testis

Carbosilane Dendrimers to Transfect Human Astrocytes with Small Interfering RNA Targeting Human Immunodeficiency Virus

Evaluating the role of ENOSF1 and TYMS variants as predictors in fluoropyrimidine-related toxicities: An IPD meta-analysis

Comparison of a new rapid method for the determination of adalimumab serum levels with two established ELISA kits

Genetic predictors of long-term response and trough levels of infliximab in crohn’s disease

Identification of new SNPs associated with severe toxicity to capecitabine

Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children

Cost-effectiveness of screening for DPYD polymorphisms to prevent neutropenia in cancer patients treated with fluoropyrimidines

Association between HLA DNA Variants and Long-Term Response to Anti-TNF Drugs in a Spanish Pediatric Inflammatory Bowel Disease Cohort

The Effect of Polymorphisms and Other Biomarkers on Infliximab Exposure in Paediatric Inflammatory Bowel Disease: Development of a Population Pharmacokinetic Model

Suchergebnisse filtern